CORCEPT THERAPEUTICS INC 4
4 · CORCEPT THERAPEUTICS INC · Filed Feb 10, 2014
Insider Transaction Report
Form 4
LeDoux Anne M
VP & Controller
Transactions
- Award
Stock option (right to buy)
[F1]2014-02-06+60,000→ 60,000 totalExercise: $3.02Exp: 2024-02-06→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]Exercisable with respect to 2.08334% of the total number of Option Shares on the monthly anniversary of 2/6/2014 and each month thereafter.
Signature
/s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated, attorney-in-fact|2014-02-10